Paller M S
Department of Medicine, University of Minnesota, Minneapolis 55455.
Am J Physiol. 1988 Sep;255(3 Pt 2):F539-44. doi: 10.1152/ajprenal.1988.255.3.F539.
In ischemic acute renal failure oxygen free radicals may mediate injury. In addition, iron appears to play a critical role in hydroxyl radical formation and lipid peroxidation during reperfusion of ischemic kidneys. To determine whether iron may play a similar role in pigment (heme protein)-induced acute renal failure, we studied the effects of the iron chelator deferoxamine in two experimental models of pigment-induced acute renal failure, intramuscular glycerol injection and intravenous hemoglobin infusion without and with concurrent ischemia in the rat. Intramuscular injection of 50% glycerol (5 ml/kg) caused inulin clearance to fall to 0.13 +/- 0.03 (SE) ml/min (normal value, 1.0-1.2 ml/min). Continuous infusion of deferoxamine beginning at the time of glycerol injection significantly attenuated this renal dysfunction. Deferoxamine-treated animals had an inulin clearance of 0.37 +/- 0.06 ml/min (P less than 0.01). Glycerol injection was also associated with significant lipid peroxidation, measured as renal malondialdehyde content. Deferoxamine-treated glycerol-injected rats had renal malondialdehyde content not significantly different from control animals. In another model of heme pigment-induced renal injury, hemoglobin was infused to produce hemoglobinuria. Inulin clearance 1 h after hemoglobin infusion was significantly reduced to 0.84 +/- 0.5 ml/min (P less than 0.025). Infusion of deferoxamine after hemoglobin prevented the hemoglobin-induced decrease in inulin clearance. Thirty minutes of renal ischemia followed by infusion of hemoglobin resulted in more severe renal dysfunction with inulin clearance of 0.54 +/- 0.08 ml/min. Deferoxamine infused at the time of reperfusion attenuated the fall in glomerular filtration rate after ischemia and hemoglobin infusion:inulin clearance 1.04 +/- 0.07 (P less than 0.005).(ABSTRACT TRUNCATED AT 250 WORDS)
在缺血性急性肾衰竭中,氧自由基可能介导损伤。此外,铁在缺血肾脏再灌注期间的羟自由基形成和脂质过氧化过程中似乎起着关键作用。为了确定铁在色素(血红素蛋白)诱导的急性肾衰竭中是否可能起类似作用,我们在色素诱导的急性肾衰竭的两种实验模型中研究了铁螯合剂去铁胺的作用,即大鼠肌肉注射甘油和静脉输注血红蛋白,有无同时存在缺血情况。肌肉注射50%甘油(5毫升/千克)导致菊粉清除率降至0.13±0.03(标准误)毫升/分钟(正常值为1.0 - 1.2毫升/分钟)。从注射甘油时开始持续输注去铁胺可显著减轻这种肾功能障碍。接受去铁胺治疗的动物菊粉清除率为0.37±0.06毫升/分钟(P<0.01)。甘油注射还与显著的脂质过氧化有关,以肾丙二醛含量衡量。接受去铁胺治疗的注射甘油大鼠的肾丙二醛含量与对照动物无显著差异。在另一种血红素色素诱导的肾损伤模型中,输注血红蛋白以产生血红蛋白尿。输注血红蛋白1小时后的菊粉清除率显著降至0.84±0.5毫升/分钟(P<0.025)。血红蛋白输注后输注去铁胺可防止血红蛋白诱导的菊粉清除率下降。肾缺血30分钟后再输注血红蛋白导致更严重的肾功能障碍,菊粉清除率为0.54±0.08毫升/分钟。再灌注时输注去铁胺减轻了缺血和血红蛋白输注后肾小球滤过率的下降:菊粉清除率为1.04±0.07(P<0.005)。(摘要截断于250字)